AHR has also been reported to activate transcription of the cyclin-dependent kinase inhibitor CDKN1B (p27) gene, a tumour suppressor that inhibits cyclin–cyclin-dependent kinase (CDK) interactions and maintains Rb in its hypophosphorylated state (Kolluri et al. 1999). Here, CDKN3 is linked to neoplasm.